UAB Department of Nutrition Sciences Clinical Trials Support New Weight Loss Drug Approved By FDA

The U.S. Food and Drug Administration late Tuesday approved a new diet drug tested in several clinical trials at UAB.

Dr. Tim Garvey, a UAB endocrinologist and the Chair of the Department of Nutrition Sciences, said the drug Qsymia will be an important new weapon in the fight to reduce American obesity and an epidemic of type 2 diabetes. Dr. Garvey was the primary investigator at UAB for a phase 2 and several phase 3 trials of Qsymia.

More information about the new drug Qsymia and quotes from Dr. Garvey can be found through the following links: